You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Novacyt noted that it generated $98.5 million in the first quarter of 2021, about half of which came from sales to the DHSC.
The three tests run on the firm's Vidas systems and expand the firm's footprint in vector-borne disease.
Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms.
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
The immunoassay can be used to monitor cancer cell remnants in a patient's body and help determine which patients need less invasive treatment.
The firm, a University of Edinburgh spinout, will use the funding to in-license its BioCollector liquid biopsy platform and launch initial trials.
MyHealthChecked's kit uses Yourgene Health's Clarigene SARS-CoV-2 PCR test and EKF Diagnostics' PrimeStore MTM sample collection device.
Avacta said that the deal will enable scientists to perform a laboratory test to detect the SARS-CoV-2 spike protein and some of its dominant variants.
The UK government said that everyone in England will be able to access free lateral flow testing for SARS-CoV-2 twice a week to support the reopening of society.
The test runs on DiaSorin's Liaison XL Analyzer and may be used by any lab CLIA-certified to perform moderate- or high-complexity tests, according to the FDA.